Angiosarcoma does not behave like many other cancers. Patients often say they wish they had understood early on that getting evaluated at a high-volume sarcoma clinic with expertise in angiosarcoma is crucial. Learn more in Patient Resources
Angiosarcoma has a 5-year overall survival rate of 30% and accounts for only 0.1% of adult malignancies. Unless we create a patient-driven initiative, our rare cancer will never be the focus of large-scale scientific endeavors.
